Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-258292
Filing Date
2008-12-22
Accepted
2008-12-22 16:32:36
Documents
9
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2444347
2 AXCAN HOLDINGS INC EMPLOYEE LONG TERM INCENTIVE PLAN dex1023.htm EX-10.23 43293
3 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 16976
4 SUBSIDIARIES OF AXCAN INTERMEDIATE HOLDINGS INC dex211.htm EX-21.1 14907
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 302 dex311.htm EX-31.1 8595
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 302 dex312.htm EX-31.2 8572
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 906 dex321.htm EX-32.1 3566
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 906 dex322.htm EX-32.2 3564
9 GRAPHIC g65888g66s30.jpg GRAPHIC 28143
  Complete submission text file 0001193125-08-258292.txt   2584202
Mailing Address 22 INVERNESS CENTER PARKWAY SUITE 310 BIRMINGHAM AL 35242
Business Address 22 INVERNESS CENTER PARKWAY SUITE 310 BIRMINGHAM AL 35242 205-991-8085
Axcan Intermediate Holdings Inc. (Filer) CIK: 0001444570 (see all company filings)

EIN.: 743249870 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-153896 | Film No.: 081264193
SIC: 2834 Pharmaceutical Preparations